News
T-cell Acute Lymphoblastic Leukaemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...
Dr. Amir Kol realized the striking parallels between FIP and severe COVID-19 could offer hope for millions of long COVID ...
Hodgkin's lymphoma market size is expected to increase during the forecast period (2025–2034) owing to increasing incidence, advancements in ...
Relevant biomarkers include cytokines and targets such as IL-4, IgE, IL-5, IL-13, IL-33, and TSLP (Figure 2). A number of targeted drugs are currently available, including lebrikizumab, dupilumab, and ...
Discover how targeted therapies are revolutionizing autoimmune disease treatment by offering greater precision.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results